March 3, 2021 08:10 AM ESTUpdated 09:15 AM
R&D

Eli Lil­ly claims suc­cess in a new JAK in­di­ca­tion: hair loss

Jason Mast

Editor

Over the last decade, drug­mak­ers have proven JAK in­hibitors can treat a smat­ter­ing of im­mune-re­lat­ed dis­eases rang­ing from rheuma­toid arthri­tis to Covid-19. Now Eli Lil­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times